Increased prescribing of psychotropic medication for children and adolescents during the COVID‐19 pandemic: no cause for alarm

Alain Braillon and Wendy A Rogers
Med J Aust 2023; 219 (6): . || doi: 10.5694/mja2.52071
Published online: 18 September 2023

To the Editor: We find Hazell's editorial troubling.1 In it, Hazell concludes that “rather than inappropriate, it [the increased prescription of psychotropic medications for children and adolescents during the coronavirus disease 2019 (COVID‐19) pandemic] was an example of the system working as it should”. It is unclear how the author could reach this conclusion based on the two articles2,3 cited in the editorial.

  • 1 Amiens, France
  • 2 Macquarie University, Sydney, NSW


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.